Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Progyny, Inc. PGNY

Healthcare  —  Healthcare Plans
25.44 (0.53) (2.04%) as of 25 Sep
Market cap
$2.0B
P/E
26.2×
Revenue Champion (5y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Progyny, Inc. (PGNY) Business Profile

Updated before January 2025

Company Overview

Progyny, Inc. (NASDAQ: PGNY) is a leading fertility benefits management company headquartered in New York City, United States. The company was founded in 2008 with the mission of redefining fertility and family-building benefits to help individuals achieve their dreams of parenthood. Progyny initially started as a fertility information platform but later evolved into a comprehensive benefits provider. The company went public in October 2019 and has since become a prominent player in the fertility and family-building industry. Key leadership includes David Schlanger, who serves as the Chief Executive Officer, and Mark Livingston, the Chief Financial Officer. Their leadership has been instrumental in driving the company’s growth and innovation.

Core Business Segments

Progyny operates primarily in the fertility benefits management sector, offering a range of products and services designed to support individuals and families in their fertility journeys. The company’s core business segments include:

Fertility Benefits Solutions

Progyny provides comprehensive fertility benefits solutions to employers, enabling them to offer their employees access to advanced fertility treatments. Key offerings include:

  • Smart Cycle Plan: A bundled approach to fertility treatments that covers a wide range of services, including in-vitro fertilization (IVF), egg freezing, intrauterine insemination (IUI), and genetic testing.
  • Medication Management: Progyny offers integrated pharmacy services to ensure patients receive the medications they need in a timely and cost-effective manner.
  • Emotional Support: The company provides access to mental health professionals and support groups to help individuals navigate the emotional challenges of fertility treatments.

Family-Building Support

Progyny also offers services that extend beyond fertility treatments, including:

  • Adoption and Surrogacy Assistance: Financial and logistical support for individuals pursuing adoption or surrogacy.
  • Education and Resources: Access to educational materials, webinars, and personalized guidance to help individuals make informed decisions.

Data-Driven Insights

Progyny leverages data analytics to improve outcomes and reduce costs. The company provides employers with detailed reporting and insights into the utilization and effectiveness of their fertility benefits programs.

Business Model

Progyny’s business model is centered around providing value to employers and their employees through a comprehensive and integrated approach to fertility benefits. The company partners with self-insured employers to offer fertility benefits as part of their employee health plans. Revenue is generated through:

  • Per-Member-Per-Month (PMPM) Fees: Employers pay a monthly fee based on the number of employees covered under the plan.
  • Utilization-Based Fees: Additional revenue is generated based on the utilization of fertility treatments and services.

Progyny’s integrated model ensures seamless coordination between patients, providers, and pharmacies, resulting in improved clinical outcomes and cost savings.

Strategic Direction

Progyny is focused on expanding its reach and enhancing its offerings to meet the growing demand for fertility and family-building services. Key strategic priorities include:

  • Market Expansion: The company aims to increase its client base by targeting large employers across various industries.
  • Service Diversification: Progyny is exploring opportunities to expand its services, including support for menopause and other reproductive health needs.
  • Technology Innovation: Continued investment in technology and data analytics to improve patient outcomes and operational efficiency.
  • Sustainability Goals: Progyny is committed to promoting sustainability by reducing waste in the healthcare system and supporting environmentally friendly practices.

Competitive Landscape

Progyny operates in a competitive market, facing competition from both traditional healthcare providers and specialized fertility benefits companies. Key competitors include:

  • Carrot Fertility: A fertility benefits provider offering customizable solutions for employers.
  • WINFertility: A company specializing in fertility management programs and pharmacy services.
  • Traditional Health Insurers: Large insurers like UnitedHealthcare and Aetna, which offer fertility benefits as part of their broader health plans.

Progyny differentiates itself through its comprehensive and patient-centric approach, as well as its focus on delivering superior clinical outcomes.

Risk Factors

Like any business, Progyny faces several risks that could impact its operations and financial performance. Key risks include:

  • Market Dependence: The company’s revenue is heavily dependent on the adoption of its services by employers. Economic downturns or changes in employer priorities could affect demand.
  • Regulatory Risks: Changes in healthcare regulations or policies could impact Progyny’s business model.
  • Supply Chain Disruptions: Delays or shortages in the supply of fertility medications and other resources could affect service delivery.
  • Competition: Increased competition from existing players or new entrants could pressure pricing and market share.

Recent Developments

Progyny has made significant strides in recent years, including:

  • New Client Wins: The company has added several high-profile employers to its client roster, expanding its reach and market presence.
  • Technology Enhancements: Investments in digital tools and platforms to improve patient engagement and streamline operations.
  • Global Developments: The COVID-19 pandemic highlighted the importance of employee health benefits, leading to increased interest in Progyny’s offerings.

Investment Considerations

Strengths

  • Market Leadership: Progyny is a leader in the fertility benefits space, with a strong brand and reputation.
  • Comprehensive Offerings: The company’s integrated approach sets it apart from competitors.
  • Growth Potential: Increasing awareness and demand for fertility benefits present significant growth opportunities.

Risks

  • Economic Sensitivity: The company’s performance is tied to employer spending on benefits, which could be affected by economic conditions.
  • Regulatory Uncertainty: Changes in healthcare laws could impact Progyny’s operations.
  • Competition: The fertility benefits market is becoming increasingly competitive.

Conclusion

Progyny, Inc. is well-positioned as a leader in the fertility benefits management industry. With its comprehensive offerings, innovative approach, and strong market presence, the company is poised for continued growth. However, investors should carefully consider the risks associated with the business, including market dependence and regulatory challenges. Overall, Progyny’s focus on improving access to fertility and family-building services makes it a compelling player in the healthcare sector.